| A. actinomycetemcomitans | Aggregatibacter actinomycetemcomitans |
| A. baumannii | Acinetobacter baumannii |
| AFM | Atomic force microscopy |
| Ag/DMSNPs | DMSNPs decorated with silver NPs |
| Ag@MSNPs | Nanoparticles with silver core and coated with mesoporous silica |
| AMSNPs-Si | (Agarose-Loaded Mesoporous Silica Nanoparticles) Coating Immobilized on Silicone Films |
| B. anthracis | Bacillus anthracis |
| B. subtilis | Bacillus subtilis |
| bth | bis(trimethoxysilyl)hexane |
| C. albicans | Candida albicans |
| CD | Cyclodextrin |
| C-dots | Carbon dots |
| Ceph | Ccphalosporin |
| CFU | Colony Forming Units |
| CIN | cinnamon |
| Cip | Ciprofloxacin |
| C-MSNPs | carboxilated MSNPs |
| DAMO | N-(2-aminoethyl)-3-aminopropyltrimethoxysilane |
| DDS | Drug delivery systems |
| DMSNPs | Dendritic mesoporous silica nanoparticles |
| DMSNPs-SB-Cu | DMSNPs supported copper |
| E. coli | Escherichia coli |
| E. faecalis | Enterococcus faecalis |
| ECDC | European Centre for Disease Prevention and Control |
| EFSA | European Food Safety Authority |
| EGCG | Epigallocatechin-3-gallate |
| EPR | Enhanced permeability and retention |
| EUC | eucalyptus |
| FB11 | Antibody for lipopolysaccharide (LPS) present in the Francisella tularensis |
| FB11-mFt LPS-MSNPs | MSNPs functionalized with an antibody for Ft LPS through a derivative of the O-antigen of Ft LPS |
| FM4-64FX | FM 4-64FX, fixable analog of FM 4-64 membrane stain |
| Fn | Francisella novocida |
| Ft LPS | lipopolysaccharide (LPS) present in F. tularensis (Ft) |
| Ft | Francisella tularensis |
| G− | Gram negative bacteria |
| G+ | Gram positive bacteria |
| G3 | polycationic dendrimer, poly(propyleneimine) dendrimer of third generation |
| Gel/SiO2-Gen NP coated Ti | titanium surface coated with a composite made of gelatin and “gentamicin-rich nuclei” silica nanoparticles |
| Gen | Gentamicin |
| HEK293 | Human embryonic kidney 293 cells |
| HKAIs | Histidine kinase autophosphorylation inhibitors |
| HMSNPs-LP | rod shaped hollow MSNPs with large cone shaped pores |
| HOMSNPs | Hollow oblate mesoporous silica nanoparticles |
| IAAH | Indole-3 Acetic Acid Complex |
| IBN-3 | Mesocellular foam |
| IBN-4 IAAH-MSNPs | Silver–Indole-3 Acetic Acid Complex based on IBN-4 silica nanoparticles |
| INH | Isoniazid |
| Izo | izohidrafural |
| K. pneumoniae | Klebsiella pneumoniae |
| Levo | Levofloxacin |
| LMU-1 bth@MSNPs | bis(trimethoxysilyl)hexane (bth) coated MSNPs with non-ordered pores |
| LMU-1 | Disordered mesoporous structure |
| LPS | Lipopolysaccharide |
| LB | Luria-Bertani liquid medium |
| lys | Lysozyme |
| M. morganii | Morganella morganii |
| M. smegmatis | Micobacterium smegmatis |
| MBI | 1-methyl-1H-benzimidazole |
| MCM-41 DAMO-MSNPs | MCM-41 type MSNPs functionalized with DAMO |
| MCM-41 G3-MSNPs | MCM-41 type MSNPs functionalized with G3 |
| MCM-41 MBI-MSNPs | 1-methyl-1H-benzimidazole functionalized MSNPs with MCM-41 structure |
| MCM-41 nHAp@MSNPs | nanohydroxyapatite/mesoporous silica nanoparticles |
| MCM-41 PMMA/MSNPs | Poly(methyl methacrylate) resine containing MCM-41 MSNPs |
| MCM-41 Van-MSNPs | MCM-41 type MSNPs functionalized with Vancomicin |
| MCM-41 ε-pLys-MSNPs | MCM-41 type MSNPs functionalized with ε-pLys |
| MCM-41 | Mesoporous structure with a hexagonal pattern |
| MCM-48 | Mesoporous structure with a cubic pattern |
| MIC | Minimun Inhibiory Concentration |
| MSM | Mesoporous silica materials |
| MSMAs/FSR film | Film made of mesoporous silica microcapsules with AgNPs supported onto the interior walls, incorporated onto the hydrophobic fluoro-silicone resin |
| MSMi | Mesoporous silica microtubes |
| MSNPs | Mesoporous silica nanoparticles, regardless of its shape |
| MSNPs@C-dots/RB | carbon dots and Rose Bengal embedded mesoporous silica nanoparticles |
| MSNPs-SB-Ni | MSNPs supported nickel |
| MSR-1/MSMi | Mesoporous silica microtubes (MSMi) with MSR-1 inside |
| MSR-1 | Magnetosopirrillum gryphiswalense |
| MXF | Moxifloxacin |
| Nafion@MSNPs | Nafion coated MSNPs |
| nHAp@MSNPs | nanohydroxyapatite/mesoporous silica nanoparticles |
| NMs | Nanomaterials |
| N-MSNPs | aminated MSNPs |
| NPs | Nanoparticles |
| ORA | orange |
| P. aeruginosa | Pseudomonas aeruginosa |
| P. mirabilis | Proteus mirabilis |
| PMMA | Poly(methyl methacrylate) |
| pMSN-GIC | Glass ionomer cement containing expanded-pore |
| PolyB | Polymyxin B |
| RB | Rose bengal |
| ROS | Reactive oxygen species |
| S. aureus | Staphylococcus aureus |
| S. enterica | Salmonella enterica |
| S. epidermidis | Staphylococcus epidermidis |
| S. mutans | Streptococcus mutans |
| S. oralis | Streptococcus oralis |
| SB | Schiff base |
| SBA-15 Ag/MSNPs | Mesoporous silica nanoparticles with hexagonal mesoporous structure and microporous connections decorated with silver NPs |
| SBA-15 DAMO-MSM | SBA15 mesoporous silica material functionalized with (N-(2-aminoethyl)-3-aminopropyltrimethoxysilane) |
| SBA-15 PMMA/MSNPs | Poly(methyl methacrylate) resine containing SBA-15 MSNPs |
| SBA-15 | Mesoporous structure with a hexagonal pattern and microporous connections |
| SEM | Scanning electron microscopy |
| Si-Ti-Sv | Silica-titania sieves |
| TC | Tetracycline |
| TEM | Transmission electron microscopy |
| Tre | Trehalose |
| Tre-HOMSNPs | Trehalose functionalized Hollow oblate mesoporous silica nanoparticles |
| UL-MSNPs | MSNPs coated with a liposome bilayer and functionalized with the ubiquicidin peptide (UBI29–41) |
| UV | Ultra violet |
| Van | Vancomicin |
| ε-pLys | ε-poly-l-lysine cationic polymer |